ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GOL Gol Linhas Aereas Inteligentes SA

2.715
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Gol Linhas Aereas Inteligentes SA NYSE:GOL NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 2.715 0 01:00:00

ADR Shares End Higher; Gol Shares Active

20/02/2014 11:16pm

Dow Jones News


Gol Linhas Aereas Inteli... (NYSE:GOL)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Gol Linhas Aereas Inteli... Charts.

International stocks trading in New York closed higher Thursday, with the Bank of New York index of American depositary receipts rose 0.5% to 150.39. The European index added 0.7% to 151.16, the Asian index was essentially flat at 143.84, the Latin American index rose 0.6% to 257.83 and the emerging markets index climbed 0.5% to 263.03. Among the companies with shares that actively traded were Gol Linhas Aereas Inteligentes SA (GOL, GOLL4.BR).

Air France-KLM (AFLYY, AF.FR) announced plans to buy a small stake in Gol, paying a steep premium to cement a broader alliance with Brazil's second-largest airline by traffic. The European carrier would inject $100 million into loss-making Gol, taking a nonvoting stake alongside fellow SkyTeam alliance member Delta Air Lines Inc. (DAL), which bought into the Brazilian carrier two years ago. Gol shares rose 7.9% to $4.91.

Deutsche Bank AG (DB, DBK.XE) reached an agreement to settle a 12-year legal battle with the heirs of late media mogul Leo Kirch, chipping away further at a backload of pending litigation that has weighed on Germany's largest bank's outlook. Shares were essentially flat at $48.33.

U.K. drug company GlaxoSmithKline PLC (GSK, GSK.LN) and Theravance, Inc. (THRX) said a European Union agency recommended that their new treatment for lung disease be approved for sale. The European Medicines Agency's Committee for Medicinal Products for Human Use recommended marketing authorization for Anoro, a drug for people with chronic obstructive pulmonary disease, or COPD, GlaxoSmithKline said in a statement with San Francisco-based Theravance. GlaxoSmithKline shares rose 0.9% to 56.22.

Write to Anna Prior at anna.prior@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


1 Year Gol Linhas Aereas Inteli... Chart

1 Year Gol Linhas Aereas Inteli... Chart

1 Month Gol Linhas Aereas Inteli... Chart

1 Month Gol Linhas Aereas Inteli... Chart

Your Recent History

Delayed Upgrade Clock